Last updated: June 1, 2026
Chloraprep Single Swabstick is sold in the US as a single-use skin antisepsis product. In supply-chain terms, the critical inputs are licensed manufacturing sites for the swabstick, the active antiseptic (commonly chlorhexidine gluconate), and regulated packaging components. Public supplier visibility is highest at the level of the labeled manufacturer and the parent supply chain behind the branded product.
Who are the suppliers of CHLORAPREP SINGLE SWABSTICK?
Primary supplier roles
- Labeled drug manufacturer (Finished-goods supplier): the entity that manufactures and releases the finished swabstick under FDA/CGMP for the US label.
- Active ingredient supplier (API/antiseptic input): manufacturer of the chlorhexidine gluconate used in the formulation (often sourced from multiple qualified sites).
- Packaging component suppliers: manufacturers of the swab, stick, pouch/wrapper, and absorbent materials that meet extractables/leachables and labeling requirements.
- Third-party logistics (3PL) and distributors: typically handle warehousing, distribution, and account-level replenishment, not formulation.
What matters commercially
- Swabstick products are constrained less by the antibiotic “API” bottleneck seen in oral generics and more by sterilization/cleanroom release, contract packaging capacity, and lot-by-lot QA release for the finished kit.
What entity is typically listed as the manufacturer on the CHLORAPREP SINGLE SWABSTICK label?
Answer: the labeled manufacturer is the starting point for supplier due diligence because it controls lot release, QA documentation, and regulatory accountability. For Chloraprep branded products, the label’s manufacturing/marketing company is usually the same corporate group that supplies the US market through its distribution channels.
How many companies supply CHLORAPREP SINGLE SWABSTICK in the US?
Publicly, supply is visible only for:
- the label holder / distributor named on the carton and package insert, and
- company names appearing in regulatory or listing contexts.
In practice, multiple qualified internal or contract partners may manufacture individual components, but the market-facing “supplier” count for the branded swabstick is typically one main finished-goods manufacturer per region, with backup sites used for supply continuity.
What does “supplier count” mean for swabstick antiseptics?
- Finished-goods manufacturers: 1 primary site is common; 2-site strategies exist when supply continuity is required.
- Component suppliers: multiple global sources for packaging and absorbent materials.
- API/antiseptic sourcing: multiple qualified sources may be used through raw-material controls.
Which organizations control CHLORAPREP SINGLE SWABSTICK supply chain capacity?
Key control points
- Finished-goods CGMP site(s): controls swabstick assembly, antiseptic loading, and finished-goods QA release.
- Contract packaging lines: control wrapper/pouch conversion capacity and labeling compliance.
- Sterile barrier/pack integrity validation: wrappers/pouches and absorbent materials that meet microbial and barrier testing.
- Regulatory documentation: the site’s ability to support changes to component suppliers without disruption to release and regulatory filings.
Does chlorhexidine swabstick supply depend on API availability more than packaging?
For Chloraprep swabsticks, shortages are often driven by:
- packaging conversion capacity (single-unit wrappers, swabstick assembly lines),
- QA release backlogs and transport lead times,
- and, secondarily, raw antiseptic availability.
What suppliers feed the CHLORAPREP Single Swabstick formulation and packaging?
Active antiseptic input
- Chlorhexidine gluconate is the primary active ingredient used in chlorhexidine antiseptic products.
- API is typically produced by specialized chemical manufacturers and qualified under drug substance specifications.
Swabstick format components
- Swab head material (often nonwoven or similar absorbent)
- Swab backing and stick
- Wrapper/pouch materials
- Label and carton printing substrates
- Lot-coded ink/label batches
How does CHLORAPREP SINGLE SWABSTICK distribution work in hospitals and GPOs?
Supplier visibility often shifts from manufacturing to:
- Group Purchasing Organization (GPO) contracts and
- hospital distribution agreements.
Hospitals usually buy through:
- authorized distributors,
- GPO-negotiated supply contracts,
- and sometimes direct-from-manufacturer channels for managed inventory.
What generic or private-label alternatives compete with CHLORAPREP SINGLE SWABSTICK suppliers?
The competitive set is typically “chlorhexidine skin antisepsis single-use swabs” with different branded and store-label packaging. Supplier dynamics usually mean:
- branded manufacturer(s) control their own contract manufacturing and packaging capacity,
- alternative products depend on either different contract packaging lines or parallel swabhead material supply.
Do competitors have different supplier bottlenecks?
Yes. Competitors can be exposed to:
- different wrapper/pouch resin shortages,
- different swab absorbent supply,
- different chlorhexidine raw-material qualification paths.
What supplier-risk indicators should buyers track for CHLORAPREP SINGLE SWABSTICK?
- Lot release delays: extended lead times between manufacturing and distribution.
- Backorder frequency at distributors: persistent stockouts indicate constrained capacity.
- Packaging line downtime: swabstick assembly is sensitive to wrapper conversion and label application.
- Component lead-time drift: packaging and absorbent components tend to show lead-time inflation first.
- Recall or quality events: any lot-level issues can remove swathes of inventory.
Key Takeaways
- “Suppliers” for CHLORAPREP Single Swabstick must be mapped in tiers: finished-goods manufacturer, active antiseptic input sources, and contract packaging/kit component partners.
- Market-facing supply is typically dominated by one main labeled finished-goods supplier per region, supported by backup sites for continuity.
- Supply constraints for swabstick products usually concentrate in packaging conversion capacity and finished-goods release timing rather than API-only bottlenecks.
- For procurement and continuity planning, the most actionable supplier-risk data comes from lot-release lead times, distributor backorder behavior, and packaging line capacity continuity.
FAQs
- Who is the listed manufacturer of CHLORAPREP Single Swabstick on the package label?
- Are there authorized distributors for CHLORAPREP Single Swabstick, and how do they manage backorders?
- What components (swab, wrapper, absorbent) determine availability for single-use chlorhexidine swabsticks?
- Do swabstick shortages correlate more with packaging supply than chlorhexidine raw material?
- What due diligence documents should hospital buyers request from suppliers for single-use antisepsis swabsticks (COA, lot traceability, chain of custody)?
